The High Stakes of Hypertension

Primary tabs

The High Stakes of Hypertension

Ann Aerts, Head of Novartis Foundation

Multimedia from this Release

Ann Aerts, Head of Novartis Foundation

Monday, June 6, 2016 - 1:40pm

CONTENT: Blog

BASEL – Most of us know about hypertension – at least we think we do. We understand that abnormally high blood pressure puts us at greater risk of heart attacks and stroke. And we also know that it is linked to diet and lifestyle, and can be treated with the right medication. But many would say that hypertension is primarily a “rich-country” problem, implying that most affected people have access to the right knowledge and treatment. That is not the case at all.

Hypertension affects a staggering one billion people worldwide, and is responsible for nearly ten million deaths annually – as many as all infectious diseases combined. Furthermore, most of the disease burden from hypertension occurs in low- and middle-income countries (LMICs), where people develop the disease at a younger age and experience worse outcomes than in high-income countries. You are far more likely to die from hypertension-related complications in Ghana, Mongolia, or Vietnam than you are in Britain, France, or the United States.

Keywords: Health & Healthcare | High blood pressure | Novartis Foundation | Philanthropy & Cause Initiatives | Sustainable Finance & Socially Responsible Investment | Wellness | healthcare innovation | hypertension

CONTENT: Blog

parse.ly